Global Non-Invasive Prenatal Testing (NIPT) Market Overview:
Global Non-Invasive Prenatal Testing (NIPT) Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Non-Invasive Prenatal Testing (NIPT) Market Report 2025 comes with the extensive industry analysis with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Non-Invasive Prenatal Testing (NIPT) involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Non-Invasive Prenatal Testing (NIPT) Market:
The Non-Invasive Prenatal Testing (NIPT) Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Non-Invasive Prenatal Testing (NIPT) Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Non-Invasive Prenatal Testing (NIPT) Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Non-Invasive Prenatal Testing (NIPT) market has been segmented into:
Consumables & Reagents
Instruments
By Application, Non-Invasive Prenatal Testing (NIPT) market has been segmented into:
Cell-free DNA in Maternal Plasma Tests
Ultrasound Detection
Biochemical Screening Tests
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Non-Invasive Prenatal Testing (NIPT) market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Non-Invasive Prenatal Testing (NIPT) market.
Top Key Players Covered in Non-Invasive Prenatal Testing (NIPT) market are:
Agilent Technologies Inc.
Berry Genetics Inc.
BGI Genomics Co. Ltd.
Eurofins LifeCodexx GmbH
F. Hoffmann-La Roche Ltd.
GE Healthcare
Igenomix
Illumina Inc.
Laboratory Corporation of America Holdings
Natera Inc.
PerkinElmer Inc.
Thermo Fisher Scientific Inc.
Yourgene Health
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Non-Invasive Prenatal Testing (NIPT) Market Type
4.1 Non-Invasive Prenatal Testing (NIPT) Market Snapshot and Growth Engine
4.2 Non-Invasive Prenatal Testing (NIPT) Market Overview
4.3 Consumables & Reagents
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Consumables & Reagents: Geographic Segmentation Analysis
4.4 Instruments
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Instruments: Geographic Segmentation Analysis
Chapter 5: Non-Invasive Prenatal Testing (NIPT) Market Application
5.1 Non-Invasive Prenatal Testing (NIPT) Market Snapshot and Growth Engine
5.2 Non-Invasive Prenatal Testing (NIPT) Market Overview
5.3 Cell-free DNA in Maternal Plasma Tests
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Cell-free DNA in Maternal Plasma Tests: Geographic Segmentation Analysis
5.4 Ultrasound Detection
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Ultrasound Detection: Geographic Segmentation Analysis
5.5 Biochemical Screening Tests
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Biochemical Screening Tests: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Non-Invasive Prenatal Testing (NIPT) Market Share by Manufacturer (2025)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 AGILENT TECHNOLOGIES
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 INC.; BERRY GENETICS INC.; BGI GENOMICS CO. LTD.; EUROFINS LIFECODEXX GMBH; F. HOFFMANN-LA ROCHE LTD.; GE HEALTHCARE; IGENOMIX; ILLUMINA
6.4 INC.; LABORATORY CORPORATION OF AMERICA HOLDINGS; NATERA
6.5 INC.; PERKINELMER INC.; THERMO FISHER SCIENTIFIC INC.; YOURGENE HEALTH
Chapter 7: Global Non-Invasive Prenatal Testing (NIPT) Market By Region
7.1 Overview
7.2. North America Non-Invasive Prenatal Testing (NIPT) Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Consumables & Reagents
7.2.2.2 Instruments
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Cell-free DNA in Maternal Plasma Tests
7.2.3.2 Ultrasound Detection
7.2.3.3 Biochemical Screening Tests
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Non-Invasive Prenatal Testing (NIPT) Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Consumables & Reagents
7.3.2.2 Instruments
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Cell-free DNA in Maternal Plasma Tests
7.3.3.2 Ultrasound Detection
7.3.3.3 Biochemical Screening Tests
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Non-Invasive Prenatal Testing (NIPT) Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Consumables & Reagents
7.4.2.2 Instruments
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Cell-free DNA in Maternal Plasma Tests
7.4.3.2 Ultrasound Detection
7.4.3.3 Biochemical Screening Tests
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Non-Invasive Prenatal Testing (NIPT) Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Consumables & Reagents
7.5.2.2 Instruments
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Cell-free DNA in Maternal Plasma Tests
7.5.3.2 Ultrasound Detection
7.5.3.3 Biochemical Screening Tests
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Non-Invasive Prenatal Testing (NIPT) Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Consumables & Reagents
7.6.2.2 Instruments
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Cell-free DNA in Maternal Plasma Tests
7.6.3.2 Ultrasound Detection
7.6.3.3 Biochemical Screening Tests
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Non-Invasive Prenatal Testing (NIPT) Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Consumables & Reagents
7.7.2.2 Instruments
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Cell-free DNA in Maternal Plasma Tests
7.7.3.2 Ultrasound Detection
7.7.3.3 Biochemical Screening Tests
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Non-Invasive Prenatal Testing (NIPT) Scope:
|
Report Data
|
Non-Invasive Prenatal Testing (NIPT) Market
|
|
Non-Invasive Prenatal Testing (NIPT) Market Size in 2025
|
USD XX million
|
|
Non-Invasive Prenatal Testing (NIPT) CAGR 2025 - 2032
|
XX%
|
|
Non-Invasive Prenatal Testing (NIPT) Base Year
|
2024
|
|
Non-Invasive Prenatal Testing (NIPT) Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Agilent Technologies Inc., Berry Genetics Inc., BGI Genomics Co. Ltd., Eurofins LifeCodexx GmbH, F. Hoffmann-La Roche Ltd., GE Healthcare, Igenomix, Illumina Inc., Laboratory Corporation of America Holdings, Natera Inc., PerkinElmer Inc., Thermo Fisher Scientific Inc., Yourgene Health.
|
|
Key Segments
|
By Type
Consumables & Reagents
Instruments
By Applications
Cell-free DNA in Maternal Plasma Tests
Ultrasound Detection
Biochemical Screening Tests
|
